“Readings obtained with ambulatory blood pressure monitoring (ABPM) are more strongly associated with risks of all-cause and cardiovascular mortality than are measurements taken in the clinic, a large Spanish registry study affirms.”
Visit Website“A relatively new biomarker being explored in the field of cardiac event prevention, fibroblast growth factor 23 (FGF-23), may be associated with death and secondary adverse events following ACS, according to an analysis of the SOLID-TIMI 52 trial.”
Visit Website“To reduce the risk of cardiovascular disease in adults with diabetes, the focus should be on appropriate lifestyle and pharmacological interventions—including aspirin, statins, and blood pressure-lowering medications—to adequately control risk factors, according to a new review from a group of primary care physicians and internal medicine specialists.”
Visit Website“The number of heart donors who died from drug overdoses has soared since 2000, and according to new data, patients who receive these organs are just as likely to have successful transplants as those who receive hearts from donors who died of medical causes or trauma.”
Visit Website“Firmware updates are now available to correct two previously reported issues affecting certain implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) made by Abbott (following the acquisition of St. Jude Medical).”
Visit Website“Instantaneous wave-free ratio (iFR) pullback provides a “physiological map of lesion severity” in patients with coronary artery disease that is difficult to characterize with standard fractional flow reserve (FFR), and this added detail can, in turn, inform the revascularization strategy, new observational data confirm.”
Visit Website“A smartphone app designed to boost adherence to antihypertensive medication among individuals with poorly controlled hypertension has only a small impact on adherence scores and no impact on systolic blood pressure levels, a new study shows.”
Visit Website“Women who’ve had a myocardial infarction are less likely to be treated with a high-intensity statin than men, and while the disparity is evident across all subgroups, some women fare worse than others, according to a new study.”
Visit Website“An implantable device that narrows the coronary sinus appears to be a good option for patients with refractory angina who are not candidates for further revascularization, real-world results from a single-center study suggest.”
Visit Website“While the burden of cardiovascular disease has declined overall in the United States, many geographic areas lag behind others, with some even showing increasing trends.”
Visit Website